BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 34943855)

  • 41. [Genetic and epigenetic landscape of pediatric T-cell acute lymphoblastic leukemia].
    Kimura S
    Rinsho Ketsueki; 2019; 60(5):459-467. PubMed ID: 31168014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship between epigenetic changes in Wnt antagonists and acute leukemia.
    Zhou HR; Fu HY; Wu DS; Zhang YY; Huang SH; Chen CJ; Yan JG; Huang JL; Shen JZ
    Oncol Rep; 2017 May; 37(5):2663-2671. PubMed ID: 28440495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biology of childhood acute lymphoblastic leukemia.
    Bhojwani D; Yang JJ; Pui CH
    Pediatr Clin North Am; 2015 Feb; 62(1):47-60. PubMed ID: 25435111
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Role of Histone Protein Modifications and Mutations in Histone Modifiers in Pediatric B-Cell Progenitor Acute Lymphoblastic Leukemia.
    Janczar S; Janczar K; Pastorczak A; Harb H; Paige AJ; Zalewska-Szewczyk B; Danilewicz M; Mlynarski W
    Cancers (Basel); 2017 Jan; 9(1):. PubMed ID: 28054944
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epigenetic mechanisms in AML - a target for therapy.
    Oki Y; Issa JP
    Cancer Treat Res; 2010; 145():19-40. PubMed ID: 20306243
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting epigenetic DNA and histone modifications to treat kidney disease.
    Fontecha-Barriuso M; Martin-Sanchez D; Ruiz-Andres O; Poveda J; Sanchez-Niño MD; Valiño-Rivas L; Ruiz-Ortega M; Ortiz A; Sanz AB
    Nephrol Dial Transplant; 2018 Nov; 33(11):1875-1886. PubMed ID: 29534238
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epigenetic deregulation in pediatric acute lymphoblastic leukemia.
    Chatterton Z; Morenos L; Mechinaud F; Ashley DM; Craig JM; Sexton-Oates A; Halemba MS; Parkinson-Bates M; Ng J; Morrison D; Carroll WL; Saffery R; Wong NC
    Epigenetics; 2014 Mar; 9(3):459-67. PubMed ID: 24394348
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeted Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia-Therapy and Toxicity Mechanisms.
    Lejman M; Kuśmierczuk K; Bednarz K; Ostapińska K; Zawitkowska J
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of epigenetic in leukemia: From mechanism to therapy.
    Liu XL; Liu HQ; Li J; Mao CY; He JT; Zhao X
    Chem Biol Interact; 2020 Feb; 317():108963. PubMed ID: 31978391
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reasons for optimism in the therapy of acute leukemia.
    Rowe JM
    Best Pract Res Clin Haematol; 2015; 28(2-3):69-72. PubMed ID: 26590761
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA methylation and miRNA expression profiling in childhood B-cell acute lymphoblastic leukemia.
    Chatterton Z; Morenos L; Saffery R; Craig JM; Ashley D; Wong NC
    Epigenomics; 2010 Oct; 2(5):697-708. PubMed ID: 22122053
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The growing role of epigenetics in childhood cancers.
    Panditharatna E; Filbin MG
    Curr Opin Pediatr; 2020 Feb; 32(1):67-75. PubMed ID: 31895160
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genomic characterization of childhood acute lymphoblastic leukemia.
    Mullighan CG
    Semin Hematol; 2013 Oct; 50(4):314-24. PubMed ID: 24246699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cancer Stem Cells in the Development of Novel Therapeutics for Refractory Pediatric Leukemia.
    Brennan L; Narendran A
    Stem Cells Dev; 2019 Oct; 28(19):1277-1287. PubMed ID: 31364487
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epigenetic targeting of Notch1-driven transcription using the HDACi panobinostat is a potential therapy against T-cell acute lymphoblastic leukemia.
    Waibel M; Vervoort SJ; Kong IY; Heinzel S; Ramsbottom KM; Martin BP; Hawkins ED; Johnstone RW
    Leukemia; 2018 Jan; 32(1):237-241. PubMed ID: 28914259
    [No Abstract]   [Full Text] [Related]  

  • 56. Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options.
    Stumpel DJ; Schneider P; van Roon EH; Boer JM; de Lorenzo P; Valsecchi MG; de Menezes RX; Pieters R; Stam RW
    Blood; 2009 Dec; 114(27):5490-8. PubMed ID: 19855078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Maternal Haplotypes in
    Tisato V; Muggeo P; Lupiano T; Longo G; Serino ML; Grassi M; Arcamone E; Secchiero P; Zauli G; Santoro N; Gemmati D
    Genes (Basel); 2019 Aug; 10(9):. PubMed ID: 31443485
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epigenetic regulation of microRNAs in acute lymphoblastic leukemia.
    Roman-Gomez J; Agirre X; Jiménez-Velasco A; Arqueros V; Vilas-Zornoza A; Rodriguez-Otero P; Martin-Subero I; Garate L; Cordeu L; San José-Eneriz E; Martin V; Castillejo JA; Bandrés E; Calasanz MJ; Siebert R; Heiniger A; Torres A; Prosper F
    J Clin Oncol; 2009 Mar; 27(8):1316-22. PubMed ID: 19164206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epigenetic analysis of childhood acute lymphoblastic leukemia.
    Dunwell TL; Hesson LB; Pavlova T; Zabarovska V; Kashuba V; Catchpoole D; Chiaramonte R; Brini AT; Griffiths M; Maher ER; Zabarovsky E; Latif F
    Epigenetics; 2009 Apr; 4(3):185-93. PubMed ID: 19430199
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Epigenetic regulatory mechanisms and their disorders in leukemia].
    Gaál Z; Oláh E
    Magy Onkol; 2014 Jun; 58(2):99-107. PubMed ID: 25010758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.